Cilostazol for treating nonalcoholic fatty liver disease
Treatments studied
Part of Digestive system clinical trials.
This study tests whether a medicine called cilostazol can help treat nonalcoholic fatty liver disease. It is for adults who have fatty liver seen on an ultrasound and do not have other liver problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have been told you have fatty liver after an ultrasound scan of your belly
- You do not drink too much alcohol (more than 2 drinks a day for men, or 1.5 drinks a day for women)
- You do not have other liver diseases like hepatitis B, hepatitis C, or drug-induced liver injury
- You do not have chronic kidney disease, parathyroid problems, or congestive heart failure
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called erdosteine can help treat non-alcoholic fatty liver disease (a condition where extra fat builds up in the liver, not caused by alcohol). It is for adults who have fatty liver confirmed by ultrasound and who do not have other serious health problems.
This study tests a medicine called carbocisteine to see if it can help treat nonalcoholic fatty liver disease (NAFLD). If you have a fatty liver and no other liver or kidney conditions, this trial may explore whether this drug is safe and effective for you.
This study tests whether the drug cilostazol can help prevent another stroke or mini-stroke (TIA) in people who have already had one. It compares adding cilostazol to the standard blood-thinning medicines you and your doctor would normally use.
This trial tests whether the drug cilostazol can help prevent another stroke and slow down damage to the brain's small blood vessels. It may be a good option if you have recently had a small-vessel stroke and have white matter changes on your MRI.
This trial tests whether taking cilostazol and aspirin together can help prevent heart attacks, strokes, and other cardiovascular events in people with type 2 diabetes who have early signs of artery disease or metabolic syndrome. It aims to see if this combination is more effective than aspirin alone.
This study tests whether a specially designed gut bacteria treatment can help people with fatty liver disease and related health issues like high blood sugar, high cholesterol, or high blood pressure. It aims to see if the treatment is safe and improves liver health.
Hear when a new Fatty Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.